Journals / Medicine Science / 2018 / Cilt: 7 - Sayı: 1

Cardiogenic shock as a first presentation in acute myocardial infarction in Egyptian’s patients and its outcome

Pages
43–50
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Cases with CS were older in age, had a higher incidence of diabetes mellitus, angina, previous MI and heart failure, a larger size of infarction, as reflected in increased level of cardiac enzymes, and was found in patients with CS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cardiogenic shock secondary to acute myocardial infarction continues to be a frustrating problem of great clinical significance.
📊
Key Findings & Data:With improvements in the medical management of AMI, particularly the treatment of ventricular arrhythmias, CS has emerged as the most common cause of death (7 to 12%) of all patients admitted with myocardial infarction.
💡
Conclusion & Impact:Cases with CS were older in age, had a higher incidence of diabetes mellitus, angina, previous MI and heart failure, a larger size of infarction, as reflected in increased level of cardiac enzymes, and was found in patients with CS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Cardiogenic shock secondary to acute myocardial infarction continues to be a frustrating problem of great clinical significance. With improvements in the medical management of AMI, particularly the treatment of ventricular arrhythmias, CS has emerged as the most common cause of death (7 to 12%) of all patients admitted with myocardial infarction. Was to minimise the impact of acute MI and/or its complications especially cardiogenic shock by early detection and rapid diagnosis to improve management processes. The study was descriptive, comprehensive study that included 60 patients presented with acute myocardial infarction with or without cardiogenic shock. Firstly assessed clinical, Electrocardiography and cardiac enzymes with treatment accordingly to Advanced Cardiac Life Support (ACLS) guidelines and treat the life threading conditions if present with follow-up throughout their hospital stays for Major Adverse Cardiac Events (MACE) that included death, reinfarction. The incidence of cardiogenic shock as the presenting problem in acute MI was 13.3%. The Patients with cardiogenic shock stayed more in the hospital with significantly more incidence of reinfarction and in-hospital mortality. Cases with CS were older in age, had a higher incidence of diabetes mellitus, angina, previous MI and heart failure, a larger size of infarction, as reflected in increased level of cardiac enzymes, and was found in patients with CS.

🔖

Cite This Article

ELBAİH1, A. H., ELSAYED, A. G., NASR, G. M., RAYAN, M. M. (2018). Cardiogenic shock as a first presentation in acute myocardial infarction in Egyptian’s patients and its outcome. Medicine Science, Cilt: 7 - Sayı: 1, 43–50. https://ajindex.com/articles/277153

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J, Jacobs A, Slater J, Miller D, Wasserman H. Current spectrum of cardiogenic shock and effect of early revascularisation on mortality. Results of an international registry. SHOCK registry investigators. Circulation. 1995;91(3):873-81.
  2. Giannuzzi P, Imparato A, Temporelli PL, de Vito F, Silva PL, Scapellato F, Giordano A. Doppler derived mitral deceleration time of early filling as a strong predictor of pulmonary capillary wedge pressure in post-infarction patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 1994;23(7):1630-7.
  3. Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy; a systemic review. Eur Heart J. 2006;27(13):1523-9. Steg PG1, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, Leizorovicz A, Touboul P; Comparison of Angioplasty and Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators. Impact of time to treatment on mortality after prehospital fibrinolyis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation. 2203;108(23):2851-6. Lindholm MG1, Køber L, Boesgaard S, Torp-Pedersen C, Aldershvile J; Trandolapril Cardiac Evaluation study group. Cardiogenic shock complicating acute myocardial infarction: prognostic impact of early and late shock development. Eur Heart J. 2003;24(3):258-65. Rao SV1, Eikelboom JA, Granger CB, Harrington RA, Califf RM, Bassand JP. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28(10):1193-204. Stramba-Badiale M1, Fox KM, Priori SG, Collins P, Daly C, Graham I, Jonsson B, Schenck-Gustafsson K, Tendera M. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J. 2006;27(8):995-1005. Thygesen K1, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J. 2007;28(20):2525-38. Guo L1, Mai X, Deng J, Liu A, Bu L, Wang H. Early percutaneous intervention improves survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock. Kardiol Pol. 2008;66(7):722-6. Braždžionytė J, Macas A. Impedance cardiography of aortic balloon counterpulsation impact assessment on patient’s hemodynamics during acute myocardial infarction. Medicina (Kaunas). 2006;42(11):90